LONG-TERM COMBINED DILTIAZEM AND BETA-BLOCKER THERAPY

被引：0
|
作者：
WYNNE, BM [1 ]
MCGRAW, BF [1 ]
HEMBERGER, JA [1 ]
机构：
[1] MARION LABS,DEPT CLIN RES,KANSAS CITY,MO
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1983年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：212 / 212
页数：1
相关论文
共 50 条
  • [41] Discontinuing of long-term beta-blocker therapy may falsely overestimate the fixed defects in dipyridamole myocardial perfusion imaging
    Beiki, D.
    Fallahi, B.
    Akbarpour, S.
    Akhzari, F.
    Izadyar, S.
    Esmaeili, J.
    Saghari, M.
    Eftekhari, M.
    Fard-Esfahani, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S387 - S387
  • [42] The Relationship Between Severe Complications, Beta-Blocker Therapy and Long-Term Survival Following Emergency Surgery for Colon Cancer
    Ahl, Rebecka
    Matthiessen, Peter
    Cao, Yang
    Sjolin, Gabriel
    Ljungqvist, Olle
    Mohseni, Shahin
    WORLD JOURNAL OF SURGERY, 2019, 43 (10) : 2527 - 2535
  • [43] Long-term prognostic value of peak VO2 in patients with heart failure on chronic beta-blocker therapy
    Metra, M.
    Nodari, S.
    Bordonali, T.
    Lombardi, C.
    Saporetti, A.
    Fracassi, F.
    Danesi, R.
    Cas, L. Dei
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 19 - 20
  • [44] Is Long-Term Beta-Blocker Therapy for Myocardial Infarction Survivors Still Relevant in the Era of Primary Percutaneous Coronary Intervention?
    Shacham, Yacov
    Leshem-Rubinow, Eran
    Roth, Arie
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2013, 15 (12): : 770 - 774
  • [45] HEMODYNAMIC CONSEQUENCES OF LONG-TERM BETA-BLOCKER THERAPY - 5-YEAR FOLLOW-UP-STUDY OF ATENOLOL
    LUNDJOHANSEN, P
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1979, 1 (05) : 487 - 495
  • [46] The Relationship Between Severe Complications, Beta-Blocker Therapy and Long-Term Survival Following Emergency Surgery for Colon Cancer
    Rebecka Ahl
    Peter Matthiessen
    Yang Cao
    Gabriel Sjolin
    Olle Ljungqvist
    Shahin Mohseni
    World Journal of Surgery, 2019, 43 : 2527 - 2535
  • [47] WHICH SUBGROUP OF PATIENTS WITH DILATED CARDIOMYOPATHY WOULD BENEFIT FROM LONG-TERM BETA-BLOCKER THERAPY - A HISTOLOGIC VIEWPOINT
    YAMADA, T
    FUKUNAMI, M
    OHMORI, M
    IWAKURA, K
    KUMAGAI, K
    KONDOH, N
    MINAMINO, T
    TSUJIMURA, E
    NAGAREDA, T
    KOTOH, K
    HOKI, N
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (03) : 628 - 633
  • [48] Effect of Beta-Blocker on Long-Term Major Cardiovascular Events in High Atherosclerotic Risk Population
    Osataphan, Nichanan
    Udol, Kamol
    Siriwattana, Khanchai
    Sukanandachai, Bancha
    Gunaparn, Siriluck
    Sirikul, Wachiranun
    Phrommintikul, Arintaya
    Wongcharoen, Wanwarang
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (06) : 1327 - 1335
  • [49] Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users
    Ramdas, Wishal D.
    van der Velde, Nathalie
    van der Cammen, Tischa J. M.
    Wolfs, Roger C. W.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (09) : 1235 - 1241
  • [50] Long-term prognostic impact of beta-blocker prescription during hospitalization for acute myocardial infarction
    Fernando Manuel Fonseca Goncalves, F. M.
    Guimaraes, J. P.
    Mateus, P. S.
    Moreira, J. I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 138 - 138
12345